Week Ending November 14, 2022
Lung Cancer: Ending the Stigma
“The American Cancer Society estimated that in 2022 more than 130,000 people will die from lung cancer, close to the equivalent of the city of Dayton’s population (137,571 in 2021 census). Lung cancer deaths make up roughly 25% of all cancer deaths—more than breast, colon, and prostate cancers combined.”
He ‘felt great.’ But a lung cancer screening test said otherwise.
Your doctor can help you get a low-dose CT scan
“As a student at West Virginia University in the late 70s, John Vance picked up a night shift working security at a private dorm. The extra income was nice, but there wasn’t much to do.”
Detecting Lung Cancer on the Move
“In 2002, 53-year-old David Sturges made an appointment with a cardiologist to screen for heart disease, which ran in his family. He underwent electron beam computed tomography (CT) to check calcification in the arteries, an indicator of the disease.”
FDA approves tremelimumab regimen for metastatic non-small cell lung cancer
“The FDA approved tremelimumab in combination with durvalumab and platinum-based chemotherapy for certain patients with metastatic non-small cell lung cancer.”
New program aims to identify lung cancers earlier that may otherwise go undetected
COLUMBUS, Ohio – “A common imaging test used for injuries and illnesses could have a secondary and important benefit: capturing subtle, early signs of lung cancer.”
International Study Shows Liquid Biopsies May Improve Lung Cancer Survival
“Moments after getting bad news about her lung cancer, Joyce Tyson got some good news. An experimental blood test called a liquid biopsy suggested a different treatment, which turned around her prognosis (outcome) for stage 4 lung cancer. Now that test can offer hope to more patients like Joyce, according to a new study published by researchers at Memorial Sloan Kettering Cancer Center (MSK).”
Lung Cancer Detection and Treatment Strengthened by Protein Discovery
“Researchers studying the mechanics of the early stages of lung cancer have identified a new potential treatment that may also aid early in detection of the disease. A group, led by researchers from the University of Edinburgh, discovered that the protein TLR2 helps control some of the body’s defense mechanisms when cancerous mutations occur in cells.”
Lung Cancer Among Never-Smokers Common in Women and Men
“Lung cancer among never-smokers (LCNS) ranks as the 11th most common cancer among men and the 8th most common among women, according to research published in Lung Cancer.”
